SCHEMBL17779115

SCHEMBL17779115

N#Cc1ccc(NC(=O)c2cc(Cl)ccc2OP=O)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMPRSS4 Q9NRS4 2/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
P2RX1 P51575 1/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45
KCNMA1 Q12791 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
ALDH1A1 P00352 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17770420 0.87 TMPRSS4 (0.46) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL17770333 0.86 TMPRSS4 (0.46) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL17770334 0.84 TMPRSS4 (0.46) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL30771735 0.82 TMPRSS4 (0.70) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL14885885 0.82 TMPRSS4 (0.70) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL19630873 0.81 PDK1 (0.43) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL17770439 0.80 HDAC1 (0.42) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL17770385 0.79 GPR6 (0.42) TMPRSS4KMT2AMEN1P2RX1PDK1
SCHEMBL19612092 0.78 ALDH1A1 (0.47) KMT2AMEN1CYP3A4ALDH1A1KDM4E
SCHEMBL19630853 0.76 P2RX7 (0.47) TMPRSS4KMT2AMEN1GPR6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016081599-A1 NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-05-26 WO disclosed